ZS-9, a Novel Selective Potassium Trap, Rapidly Reduced Serum Potassium in Patients with Diabetes Treated for Hyperkalemia

被引：0

|

作者：

Rasmussen, Henrik S.

Block, Geoffrey A.

Lavin, Philip T.

El-Shahawy, Mohamed A.

Roger, Simon D.

Packham, David K.

Yang, Alex

Singh, Bhupinder

机构：

来源：

DIABETES | 2014年 / 63卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1139-P

引用

收藏

页码：A296 / A296

页数：1

相关论文

共 22 条

[21] Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Once-Daily ZS-9 for Treatment of Hyperkalemia: Maintenance of Serum K+ in Subgroup Analysis of Patients on RAAS Therapy
Singh, Bhupinder
Rasmussen, Henrik S.
Lavin, Philip T.
Yang, Alex
Roger, Simon D.
HYPERTENSION, 2014, 64
[22] Patiromer lowers serum potassium and prevents recurrent hyperkalemia in patients with heart failure and CKD when treated with RAAS inhibitors: results from OPAL-HK
Pitt, B.
Weir, M. R.
Mayo, M. R.
Garza, D.
Christ-Schmidt, H.
Wittes, J.
Berman, L.
EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 90 - 90